TearLab Corporation (TEAR)
TearLab Corporation Capital Expenditures: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TEAR Capital Expenditures Rankings
| Overall | 99th percentile | 1 of 4457 |
| Sector | 99th percentile | 1 of 508 in Healthcare |
| Industry | 96th percentile | 1 of 25 in Medical Laboratories & Research |
TEAR Capital Expenditures Range, Past 5 Years
| Minimum | 0.00 | Dec 2009 |
| Maximum | 0.07M | Dec 2007 |
| Average | 0.0242M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these TEAR related companies
TEAR News
TearLab to Participate in the 9th Annual Craig-Hallum Institutional Investor Conference
May 24, 8:15AM GlobeNewswire
May 24, 8:15AM GlobeNewswire
Morning Movers 05/14: (GOLF) (VTUS) (KERX) Higher; (IOC) (ACOM) (ANIK) Lower
May 14, 10:07AM Street Insider
May 14, 10:07AM Street Insider
EBR: Watchlist/worksheet/4 Trading Ideas: $CLGX $CRI $SBUX $TEAR $GOOG http://stks.co/3iT9
about 25 days ago by TheEquitiesRoom
about 25 days ago by TheEquitiesRoom
TearLab Corporation to Release Q1 2012 Financial Results on May 14, 2012
May 03, 8:30PM GlobeNewswire
May 03, 8:30PM GlobeNewswire
Study on Potential Impact of Pre-Operative Osmolarity on LASIK Outcomes to be Presented at ARVO 2012
May 01, 9:00AM GlobeNewswire
May 01, 9:00AM GlobeNewswire
TearLab Corporation Prices $10.8 Million Public Offering of Common Stock
Apr 11, 7:45AM GlobeNewswire
Apr 11, 7:45AM GlobeNewswire
UPDATE: TearLab Corporation Announces Proposed Public Offering of Common Stock
Apr 10, 4:02PM Benzinga
Apr 10, 4:02PM Benzinga
$TEAR Downside Blowoff - 15 Minute Up Reversal - Green bar after 6 red bars
about 53 days ago by TradeIdeasQuant
about 53 days ago by TradeIdeasQuant
$tear huge run today.. great call by @szaman this morning right at the open in the 3.5s
about 57 days ago by kunal00
about 57 days ago by kunal00
3 Ripe High Tight Flags for Tuesday $BONT $TEAR $IMOS http://stks.co/3C3j http://chart.ly/9njgw5m
about 60 days ago by Woodshedder
about 60 days ago by Woodshedder
RT @Fibline: $TEAR Executive interview regarding their nice day today ~ http://stks.co/33ST
about 70 days ago by WallStJesus
about 70 days ago by WallStJesus
$TEAR looking for a bit of follow thru on Mon & will take some profits !
about 70 days ago by WallStJesus
about 70 days ago by WallStJesus
$TEAR Executive interview regarding their nice day today ~ http://stks.co/33Mo
about 70 days ago by Fibline
about 70 days ago by Fibline
TearLab Corporation to Release Q4 2011 Financial Results on March 22, 2012
Mar 08, 4:30PM GlobeNewswire
Mar 08, 4:30PM GlobeNewswire
TearLab (TEAR) Reports Center for Medicare and Medicaid Approves Reconsideration Request
Dec 13, 2:41PM Street Insider
Dec 13, 2:41PM Street Insider
TearLab to Present at the 23rd Annual Piper Jaffray Healthcare Conference
Nov 22, 10:30AM GlobeNewswire
Nov 22, 10:30AM GlobeNewswire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TEAR | 3.02 | -0.22 | -6.79% | 66.16M |
| TEA | 13.04 | -0.24 | -1.81% | 508.76M |
| TE | 17.19 | -0.21 | -1.21% | 3.755B |
| TDY | 57.17 | -2.41 | -4.04% | 2.187B |
| TDW | 44.47 | -0.61 | -1.35% | 2.306B |
| TDS.S | 26.92 | +0.07 | +0.26% | |
| TDS | 19.44 | -0.41 | -2.07% | 2.153B |
| TDD | 21.62 | -0.01 | -0.05% | |
| TDC | 64.65 | -1.83 | -2.75% | 11.19B |
| TD | 73.86 | -2.51 | -3.29% | 68.96B |
